Cargando…

Staging model for amyotrophic lateral sclerosis in Singapore

INTRODUCTION: A clinical-based staging model would guide physicians in the prompt management of the evolving symptoms and functional needs of patients with amyotrophic lateral sclerosis (ALS). METHODS: We aimed to delineate the clinical trajectory of ALS in Singapore and test the degree of congruity...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Yuan Teck, Chai, Josiah YH, Jabin, Kamilah Bte Shekh, Ang, Kexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578121/
https://www.ncbi.nlm.nih.gov/pubmed/33472335
http://dx.doi.org/10.11622/smedj.2021001
_version_ 1784811908088463360
author Tay, Yuan Teck
Chai, Josiah YH
Jabin, Kamilah Bte Shekh
Ang, Kexin
author_facet Tay, Yuan Teck
Chai, Josiah YH
Jabin, Kamilah Bte Shekh
Ang, Kexin
author_sort Tay, Yuan Teck
collection PubMed
description INTRODUCTION: A clinical-based staging model would guide physicians in the prompt management of the evolving symptoms and functional needs of patients with amyotrophic lateral sclerosis (ALS). METHODS: We aimed to delineate the clinical trajectory of ALS in Singapore and test the degree of congruity of King's College staging for ALS (King's staging) among Singapore patients. In this retrospective cohort study, clinical milestones used for staging were identical to King's staging: stage 1 corresponded to symptom onset; stage 2A corresponded to diagnosis; stage 2B corresponded to two central nervous system (CNS) regions; stage 3B corresponded to three CNS regions; stage 4A corresponded to requirement of supportive enteric feeding; and stage 4B corresponded to requirement of non-invasive ventilation, of which bulbar, diaphragmatic, upper and lower limb pyramidal involvements each constituted one CNS region. Standardised timings from disease onset (0) to death (1) among Singapore patients with ALS were measured. RESULTS: 46 patients with ALS were reviewed. Results were largely congruous with King's staging. Results for patients with limb-onset ALS were: diagnosis (0.35); two CNS region involvement (0.42); three CNS region involvement (0.63); diaphragmatic involvement (0.81); and bulbar involvement (0.73). Results for patients with bulbar-onset ALS were: diagnosis (0.14); two CNS region involvement (0.28); three CNS region involvement (0.42); diaphragmatic involvement (0.62); and bulbar involvement (0.67). CONCLUSION: King's staging can be used to model ALS trajectory in Singapore due to the large degree of congruity seen. Easily remembered and accessible knowledge of ALS staging will allow prompt management of the evolving needs of patients with ALS.
format Online
Article
Text
id pubmed-9578121
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-95781212022-10-18 Staging model for amyotrophic lateral sclerosis in Singapore Tay, Yuan Teck Chai, Josiah YH Jabin, Kamilah Bte Shekh Ang, Kexin Singapore Med J Original Article INTRODUCTION: A clinical-based staging model would guide physicians in the prompt management of the evolving symptoms and functional needs of patients with amyotrophic lateral sclerosis (ALS). METHODS: We aimed to delineate the clinical trajectory of ALS in Singapore and test the degree of congruity of King's College staging for ALS (King's staging) among Singapore patients. In this retrospective cohort study, clinical milestones used for staging were identical to King's staging: stage 1 corresponded to symptom onset; stage 2A corresponded to diagnosis; stage 2B corresponded to two central nervous system (CNS) regions; stage 3B corresponded to three CNS regions; stage 4A corresponded to requirement of supportive enteric feeding; and stage 4B corresponded to requirement of non-invasive ventilation, of which bulbar, diaphragmatic, upper and lower limb pyramidal involvements each constituted one CNS region. Standardised timings from disease onset (0) to death (1) among Singapore patients with ALS were measured. RESULTS: 46 patients with ALS were reviewed. Results were largely congruous with King's staging. Results for patients with limb-onset ALS were: diagnosis (0.35); two CNS region involvement (0.42); three CNS region involvement (0.63); diaphragmatic involvement (0.81); and bulbar involvement (0.73). Results for patients with bulbar-onset ALS were: diagnosis (0.14); two CNS region involvement (0.28); three CNS region involvement (0.42); diaphragmatic involvement (0.62); and bulbar involvement (0.67). CONCLUSION: King's staging can be used to model ALS trajectory in Singapore due to the large degree of congruity seen. Easily remembered and accessible knowledge of ALS staging will allow prompt management of the evolving needs of patients with ALS. Wolters Kluwer - Medknow 2021-01-21 /pmc/articles/PMC9578121/ /pubmed/33472335 http://dx.doi.org/10.11622/smedj.2021001 Text en Copyright: © 2022 Singapore Medical Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Tay, Yuan Teck
Chai, Josiah YH
Jabin, Kamilah Bte Shekh
Ang, Kexin
Staging model for amyotrophic lateral sclerosis in Singapore
title Staging model for amyotrophic lateral sclerosis in Singapore
title_full Staging model for amyotrophic lateral sclerosis in Singapore
title_fullStr Staging model for amyotrophic lateral sclerosis in Singapore
title_full_unstemmed Staging model for amyotrophic lateral sclerosis in Singapore
title_short Staging model for amyotrophic lateral sclerosis in Singapore
title_sort staging model for amyotrophic lateral sclerosis in singapore
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578121/
https://www.ncbi.nlm.nih.gov/pubmed/33472335
http://dx.doi.org/10.11622/smedj.2021001
work_keys_str_mv AT tayyuanteck stagingmodelforamyotrophiclateralsclerosisinsingapore
AT chaijosiahyh stagingmodelforamyotrophiclateralsclerosisinsingapore
AT jabinkamilahbteshekh stagingmodelforamyotrophiclateralsclerosisinsingapore
AT angkexin stagingmodelforamyotrophiclateralsclerosisinsingapore